Search

Your search keyword '"Clumeck N."' showing total 835 results

Search Constraints

Start Over You searched for: Author "Clumeck N." Remove constraint Author: "Clumeck N."
835 results on '"Clumeck N."'

Search Results

1. Trends in mortality in people with HIV from 1999 to 2020: a multi-cohort collaboration

3. Raltegravir 1200 mg once daily versus raltegravir 400 mg twice daily, with tenofovir disoproxil fumarate and emtricitabine, for previously untreated HIV-1 infection: a randomised, double-blind, parallel-group, phase 3, non-inferiority trial

4. Risk for non-AIDS-defining and AIDS-defining cancer of early versus delayed initiation of antiretroviral therapy

5. Increased Indoleamine-2,3-Dioxygenase Activity Is Associated With Poor Clinical Outcome in Adults Hospitalized With Influenza in the INSIGHT FLU003Plus Study

6. Prevalence and Outcomes for Heavily Treatment-Experienced Individuals Living With Human Immunodeficiency Virus in a European Cohort

7. Risk for non-AIDS-defining and AIDS-defining cancer of early versus delayed initiation of antiretroviral therapy: A multinational prospective cohort study

8. Incidence of cancer and overall risk of mortality in individuals treated with raltegravir‐based and non‐raltegravir‐based combination antiretroviral therapy regimens

9. The extent of B‐cell activation and dysfunction preceding lymphoma development in HIV‐positive people†

10. The association between hepatitis B virus infection and nonliver malignancies in persons living with HIV: results from the EuroSIDA study

13. Observational cohort study of rilpivirine (RPV) utilization in Europe

14. HCV reinfection after HCV therapy among HIV/HCV-coinfected individuals in Europe

15. HIV testing history and access to treatment among migrants living with HIV in Europe

16. Gender differences in the use of cardiovascular interventions in HIV?positive persons; the D:A:D Study

17. Low-frequency drug-resistant HIV-1 and risk of virological failure to first-line NNRTI-based ART: a multicohort European case–control study using centralized ultrasensitive 454 pyrosequencing

22. Establishing a hepatitis C continuum of care among HIV/hepatitis C virus-coinfected individuals in EuroSIDA

27. Estimating prevalence of accumulated HIV-1 drug resistance in a cohort of patients on antiretroviral therapy

28. Highlights of the 2017 European AIDS Clinical Society (EACS) Guidelines for the treatment of adult HIV-positive persons version 9.0

29. Long‐term effectiveness of recommended boosted protease inhibitor‐based antiretroviral therapy in Europe

30. Incidence of cancer and overall risk of mortality in individuals treated with raltegravir-based and non-raltegravir-based combination antiretroviral therapy regimens

41. Highlights of the 2017 European AIDS Clinical Society (EACS) Guidelines for the treatment of adult HIV-positive persons version 9.0

42. Abstracts

45. Uptake and effectiveness of two-drug compared with three-drug antiretroviral regimens among HIV-positive individuals in Europe

46. Establishing a hepatitis C continuum of care among HIV/hepatitis C virus-coinfected individuals in EuroSIDA

48. Liver-related death among HIV/hepatitis C virus-co-infected individuals

50. Uptake and effectiveness of two-drug compared with three-drug antiretroviral regimens among HIV-positive individuals in Europe

Catalog

Books, media, physical & digital resources